PositoAI/ US/ IGC Pharma, Inc.

IGC Pharma, Inc.

NYSE American: IGC · Healthcare

Positivity Index

#4,429 / 6,775

Global

#2,201 / 4,000

United States

Positivity Score

19,503

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

IGC Pharma, Inc. — Overview & Financial Snapshot

IGC Pharma, Inc. (NYSE American: IGC) is a Healthcare company, ranked #4,429 of 6,775 companies globally and #2,201 of 4,000 in United States on PositoAI, with a Positivity Score of 19,503. Its market capitalisation is ₹241.72 Cr ($25.61M), P/E ratio is -3.5 and P/B ratio is 4.18. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

P/B Ratio 4.18

P/E Ratio -3.5

D/E Ratio 0.18

ROE -83.34%

Owes vs Owns ? 0.33× Low $0.33 owed for every $1 it owns · balance sheet Mar 2026

Dividend Yield 0.00%

Trailing EPS ₹-6.61$-0.07

Forward EPS ₹-7.55$-0.08

Beta 0.48

Market Cap ₹241.72 Cr$25.61M

What these numbers mean →

What does IGC Pharma, Inc. do?

What is IGC Pharma, Inc.'s P/E and P/B ratio?

IGC Pharma, Inc. has a P/E ratio of -3.5 and a P/B ratio of 4.18.

What is IGC Pharma, Inc.'s debt-to-equity ratio?

IGC Pharma, Inc. has a debt-to-equity ratio of 0.18.

How much does IGC Pharma, Inc. owe compared with what it owns?

IGC Pharma, Inc. owes $0.33 for every $1 it owns (balance sheet Mar 2026), which is low.

What is IGC Pharma, Inc.'s Positivity rank?

IGC Pharma, Inc. is ranked #4,429 of 6,775 companies globally and #2,201 of 4,000 in United States on PositoAI, with a Positivity Score of 19,503.

Does IGC Pharma, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for IGC Pharma, Inc..

Where can I read the latest news about IGC Pharma, Inc.?

Recent headlines about IGC Pharma, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does IGC Pharma, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of IGC Pharma, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.